Tumor suppressor gene mutations in mice

Annual Review of Genetics

Volumn 30, Issue , 1996, Pages 603-636

  Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

cancer; embryonic stem cells; gene knock out; mouse models; tumor suppressor genes

Indexed keywords

ANIMAL MODEL; EMBRYO DEVELOPMENT; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; SPECIES DIFFERENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; SPECIES SPECIFICITY;

EID: 0030444452     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.30.1.603     Document Type: Review

References (171)

1. al-Ubaidi MR, Font RL, Quiambao AO, Keener MJ, Liou GI, et al. 1992. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J. Cell Biol. 119:1681-87
2. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, et al. 1995. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92:5436-40
3. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 8:937-43
4. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, et al. 1990. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851-59
5. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, et al. 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10:1717-23
6. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, et al. 1996. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12:144-48
7. Bouffler SD, Kemp CD, Balmain A, Cox R. 1995. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55:3883-89
8. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, et al. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1019-29
9. Burt R, Samowitz W. 1988. The adenomatous polyp and the hereditary polyposis syndrome. Gastroenterol. Clin. North Am. 17:657-78
10. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, et al. 1995. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-91
11. Cho KR, Fearon ER. 1995. DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? Curr. Opin. Genet. Dev. 5:72-78
12. Clarke AR. 1994. Murine genetic models of human disease. Curr. Opin. Genet. Dev. 4:453-60
13. Clarke AR, Cummings MC, Harrison DJ. 1995. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 11:1913-20
14. Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, et al. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-30
15. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, et al. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-52.
16. Cobrinik D, Lee M-H, Hannon G, Mulligan G, Bronson RT, et al. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. In press
17. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, et al. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-56
18. den Bakker MA, Tascilar M, Riegman PH, Hekman AC, Boersma W, et al. 1995. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am. J. Pathol. 147:1339-49
19. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, et al. 1993. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-39
20. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, et al. 1993. Gain of function mutations in p53. Nat. Genet. 4:42-46
21. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi Y-P, et al. 1995. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9:882-95
22. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-21
23. Duan DR, Humphrey JS, Chen DY, Weng Y, Sukegawa J, et al. 1995. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc. Natl. Acad. Sci. USA 92:6459-63
24. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, et al. 1995. Inhibition of transcriptional elongation by the VHL tumor suppressor protein. Science 269:1402-6
25. Easton DF, Ponder MA, Huson SM, Ponder BA. 1993. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am. J. Hum. Genet. 53:305-13
26. Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11:181-90
27. Ewen ME, Xing Y, Lawrence JB, Livingston DM. 1991. Molecular cloning, chromosomal mapping and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-64
28. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, et al. 1990. Identification of a chromsome 18q gene that is altered in colorectal cancers. Science 247:49-56
29. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-67
30. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, et al. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27-deficient mice. Cell 733-44
31. Field S, Tsai F-Y, Kuo F, Zubiaga AM, Kaelin WG, et al. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-61
32. Fodde R, Edelman W, Yang K, van Leeuwen C, Carlson C, et al. 1994. A targeted chain-termination in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA 91:8969-73
33. Friend SJ, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, et al. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-46
34. Ginsberg D, Mechta F, Yaniv M, Oren M. 1991. Wild-type p53 can down- modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979-83
35. Ginsberg D, Vairo G, Chittenden T, Xiao Z, Xu G, et al. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-79
36. Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH. 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191-94
37. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-78
38. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, et al. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
39. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, et al. 1995. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet. 10:351-53
40. Gu H, Marth JD, Orban PC, Mossman H, Rajewsky K. 1994. Deletion of a polymerase B gene segment in T cells using cell type-specific gene targeting. Science 265:103-6
41. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MG, Shanley S, et al. 1996. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-51
42. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, et al. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-53
43. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, et al. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-23
44. Hancock LF. 1993. Anti-Ras drugs come of age. Curr. Biol. 3:770-72
45. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679-82
46. Hannon GJ, Demetrick D, Beach D. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-91
47. Harrison DJ, Hooper ML, Armstrong JF, Clarke AR. 1995. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10:1615-20
48. Harvey M, McArthur MJ, Montgomery CA, Butel JS, Bradley A, Donehower LA. 1993. Spontaneous and carcinogen-induced tumors in p53-deficient mice. Nat. Genet. 5:225-29
49. Harvey M, Vogel H, Lee EY, Bradley A, Donehower LA. 1995. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 55:1146-51
50. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, Donehower LA. 1995. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat. Genet. 305-311
51. Hastie ND. 1994. The genetics of Wilms tumor - a case of disrupted development. Annu. Rev. Genet. 28:523-58
52. Hasty P, Ramirez-Solis R, Krumlauf R, Bradley A. 1991. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350:243-46
53. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. 1991. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65:753-63
54. Henkemeyer M, Rossi DJ, Holmyard DP, Pun MC, Mbamalu G, et al. 1995. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377:695-701
55. Hino O, Klein-Szanto AJ, Freed JJ, Testa JR, Brown DQ, et al. 1993. Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc. Natl. Acad. Sci. USA 327-31
56. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, et al. 1996. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500
57. Horowitz JM, Park SH, Begenmann E, Cheng JC, Yandell DW, et al. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87:2775-79
58. Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ. 1994. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8:1300-10
59. Hsu B, Marin MC, el-Naggar AK, Stephens LC, Brisbay S, McDonnell TJ. 1995. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11:175-79
60. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY-HP. 1994. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-27
61. Jacks T, Fazeli A, Schmidt E, Bronson R, Goodell M, Weinberg R. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300
62. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, et al. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7
63. Jacks T, Shih TS, Schmitt EM, Bronson RD, Bernards A, Weinberg RA. 1994. Tumourigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nat. Genet. 7:353-61
64. Jensen RA, Thompson ME, Jetton TJ, Szabo CI, van der Meer R, et al. 1996. BRCA1 is secreted and exhibits properties of a granin. Nat. Genet. 6:303-8
65. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. 1996. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-71
66. Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-8
67. Kastan M, Zhan Q, El-Deiry WS, Carrier F, Jacks T, et al. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-97
68. Kemp CJ, Donehower LA, Bradley A, Balmain A. 1993. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813-22
69. Kemp CJ, Wheldon T, Balmain A. 1994. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8:66-69
70. Kibel A, Iliopaoulos O, DeCaprio JA, Kaelin WG. 1995. Binding of the vonHippel-Lindau tumor suppressor protein to elongin B and C. Science 269:1444-46
71. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, et al. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-65
72. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, et al. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27. Cell 85:721-32
73. Knudson AG. 1978. Retinoblastoma: a proteotypic hereditary neoplasm. Semin. Oncol. 5:57-60
74. Ko LJ, Prives C. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-72
75. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. 1995. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet. 9:70-74
76. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69:2491-500
77. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, et al. 1993. WT-1 is required for early kidney development. Cell 74:679-91
78. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269:1427-29
79. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, et al. 1995. Suppression of intestinal neoplasia by DNA methylation. Cell 81:197-205
80. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG. 1996. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat. Genet. 12:137-43
81. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, et al. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401
82. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, et al. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-20
83. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, et al. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-95
84. Lee EY-HP, Hu N, Yuan S-SF, Cox LA, Bradley A, et al. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008-21
85. Lee JM, Abrahamson JL, Kandel R, Donehower LA, Bernstein A. 1994. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9:3731-36
86. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, et al. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1621-32
87. Leppert M, Burt R, Hughes JP, Samowitz W, Nakamura Y, et al. 1990. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N. Engl. J. Med. 322:904-8
88. Li Y, Graham C, Lacy S, Duncan AMV, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-77
89. Liu F, Hata A, Baker JC, Doody J, Carcamo J, et al. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-23
90. Lotem J, Sachs L. 1995. A mutant p53 antagonizes the deregulated c-myc- mediated enhancement of apoptosis and decrease in leukemogenicity. Proc. Natl. Acad. Sci. USA 10:9672-76
91. Lowe SM, Ruley HE, Jacks T, Housman DE. 1993. p53-dependent apoptosis modulates the cytoxicity of anticancer agents. Cell 74:957-67
92. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, et al. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266:807-10
93. Lowe SW, Schmitt ES, Smith SW, Osborne BA, Jacks T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-49
94. Luongo C, Moser AR, Gledhill S, Dove WF. 1994. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res. 54:5947-52
95. Maandag ECR, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, et al. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:4260-68
96. Macleod KF, Hu Y, Jacks T. 1996. Loss of Rb activates both p53-dependent and -independent cell death pathways in the developing mouse nervous system. EMBO J. In press
97. Min-induced hyperplasia. Cell 81:957-66
98. Malkin D. 1993. p53 and the Li-Fraumeni syndrome. Cancer Genet. Cytogenet. 66:83-92
99. Marin MC, Hs B, Meyn RE, Donehower LA, el-Naggar AK, McDonnell TJ. 1994. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9:3107-12
100. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, et al. 1990. The GAP-related domain of the neurofibromatosi type 1 gene product interacts with ras p21. Cell 63:843-49
101. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. 1992. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-19
102. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-66
103. McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T. 1996. The cytoskeletal-associated Nf2 tumor suppressor gene product is essential for gastrulation and several additional stages of mouse embryogenesis. Submitted.
104. Melton DW. 1994. Gene targeting in the mouse. BioEssays 16:633-38
105. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, et al. 1994. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54:614-17
106. Michalovitz D, Halevy O, Oren M. 1991. p53 mutations: gains or losses. J. Cell. Biochem. 45:22-29
107. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
108. Montes de Oca Luna R, Wagner DS, Lozano G. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-6
109. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74
110. Min, a mutation in the murine Ape gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl. Acad. Sci. USA 8977-81
111. Moser AR, Pilot HC, Dove WF. 1990. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-24
112. Moser AR, Shoemaker AR, Connelly CS, Clipson L, Gould KA, et al. 1995. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dyn. 203:422-33
113. Nacht M, Strasser A, Chan YR, Harris A, Schlissel M, et al. 1996. Mutations in the p53 and SCID genes cooperate in lymphomagenesis. Genes Dev. 10:2055-66
114. Nakayama K, Ishida N, Shirane M, Inotnata A, Inoue T, et al. 1996. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-20
115. Nellist M, Janssen B, Brook-Carter PT, Hesseling-Jansenn ALW, Maheshwar MM, et al. 1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-15
116. Nevins J. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-29
117. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG. 1995. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet. 10:181-87
118. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S. 1996. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2:577-81
119. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, et al. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-97
120. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. 1995. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92:4482-86
121. Pan H, Griep A. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1285-99
122. Pan H, Griep AE. 1995. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9:2157-69
123. Peters G. 1990. Oncogenes at viral integration sites. Cell Growth Differ 1:503-10
124. Polakis P. 1995. Mutations in the APC gene and their implications for protein structure and function. Curr. Opin. Genet. Dev. 5:66-71
125. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, et al. 1994. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9:603-9
126. Qin XQ, Livingston DM, Kaelin WG, Adams PD. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-22
127. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000
128. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378:720-24
129. Riccardi VM. 1992. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore: Johns Hopkins Univ. Press
130. Rosenbaum T, Boissy YL, Kombrinck K, Brannan CI, Jenkins NA, et al. 1995. Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development 121:3583-92
131. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, et al. 1993. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-21
132. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. 1996. Binding of GSK3B to the APC-B-catenin complex and regulation of complex assembly. Science 272:1023-26
133. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, et al. 1993. Association of the APC gene product with beta-catenin. Science 262:1731-34
134. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-59
135. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T.1995. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:175-80
136. Sampson JR, Harris PC. 1994. The molecular genetics of tuberous sclerosis. Hum. Mol. Genet. 3:1477-80
137. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, et al. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-7
138. Scully R, Ganesan S, Brown M, De Caprio JA, et al. 1996. Location of BACA1 in human breast and ovarian cancer cells. Science 272:123-25
139. Serrano M, Hannon GJ, Beach D. 1993. A new regulatory motif in cell- cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-7
140. Serrano M, Lee H-W, Chin L, Cordon-Cardi C, Beach D, DePinho RA. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37
141. Shan B, Lee W-H. 1994. Deregulated expression of E2F-1 induces S- phase entry and leads to apoptosis. Mol. Cell. Biol. 14:299-309
142. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian Gl cyclin-dependent kinases. Genes Dev. 9:1149-63
143. Shoemaker AR, Moser AR, Dove WF. 1995. N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res. 55:4479-85
144. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, et al. 1996. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 17-26
145. Strasser A, Harris AW, Jacks T, Cory S. 1994. DNA Damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329-39
146. Su LK, Vogelstein B, Kinzler KW. 1993. Association of the APC tumor suppressor protein with catenins. Science 262:1734-37
147. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, et al. 1994. p53- dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-11
148. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, et al. 1996. The complete BRCA2 gene and mutations in chromosomal 13q-linked kindreds. Nat. Genet. 12:333-37
149. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, et al. 1993. A novel moresin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800
150. Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, et al. 1994. Enhanced cell proliferative potential in culture of cells from p53-deficient mice. Oncogene 9:603-9
151. Vairo G, Livingston D, Ginsberg D. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-81
152. Van Dyke TA. 1994. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. Semin. Can. Biol. 5:106.1-106.14
153. van Lohuizen M, Berns A. 1990. Tumorigenesis by slow-transforming retroviruses - an update. Biochim. Biophys. Acta 1032:213-35
154. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. 1991. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65:737-52
155. Vishochil D, White R, Cawthon R. 1993. The neurofibromatosis type 1 gene. Annu. Rev. Neurosci. 16:183-205
156. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF. 1995. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-42
157. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-30
158. White E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15
159. Wienecke R, Konig A, DeClue JE. 1995. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol. Chem. 270:16409-14
160. Williams BO, Remington L, Bronson RT, Mukai S, Albert DM, et al. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7:480-84
161. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, et al. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:4251-59
162. Windle JJ, Albert DA, O'Brien JM, Marcus DM, Disteche CM, et al. 1990. Retinoblastoma in transgenic mice. Nature 343:665-68
163. Wolf D, Harris N, Rotter V. 1984. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell 38:119-26
164. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-92
165. Wu X, Levine AJ. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3802-6
166. Xu G, Lin B, Tanaka K, Dunn D, Wood D, et al. 1990. The catalytic domain of the neurofibromatosis type 1 gene product stimulatesras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835-41
167. Yamasaki L, Bronson RT, Jacks T, Dyson N, Harlow E. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-48
168. Yeung RS, Xiao GH, Everitt JI, Jin F, Walker CL. 1995. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol. Carcinog. 14:28-36
169. Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG. 1994. Predisposition to renal carcinoma in the Eker rat is determined by germline mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. USA 91:11413-16
170. Yokota J, Akijama T, Funger Y-KT, Benedict WF, Namba Y, et al. 1988. Altered expression of retinoblastoma (RB) gene in small-cell lung carcinoma of the lung. Oncogene 3:471-75
171. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, et al. 1994. Sunburn and p53 in the onset of skin cancer. Nature 372:773-76